Results 171 to 180 of about 6,687,759 (284)
Spatial patterns and socio-environmental determinants of gonorrhea incidence in China. [PDF]
Hu K +6 more
europepmc +1 more source
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz +15 more
wiley +1 more source
Spike count analysis for multiplexing inference (SCAMPI). [PDF]
Chen Y, Groh JM, Tokdar S.
europepmc +1 more source
Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed +10 more
wiley +1 more source
Se realizó un estudio observacional y analítico para evaluar la utilidad de una nueva técnica de análisis estadístico implicativo en la identificación de los factores pronósticos de la mortalidad por cáncer de mama en la provincia de Santiago de Cuba ...
Alina Moraga Rodríguez +4 more
doaj
Research on the deformation mechanisms of red-bed deposits with straight line deposit-bedrock interfaces in Xiangjiaba Reservoir area. [PDF]
Xiong Y, Dai F, Qi Y, Li S.
europepmc +1 more source
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto +13 more
wiley +1 more source
Validation of the Malay Version of the Caregiver Quality of Life Index-Cancer (MCQoL) among caregivers of cancer patients in Malaysia. [PDF]
Ali A +4 more
europepmc +1 more source
Dual targeting of RET and SRC synergizes in RET fusion‐positive cancer cells
Despite the strong activity of selective RET tyrosine kinase inhibitors (TKIs), resistance of RET fusion‐positive (RET+) lung cancer and thyroid cancer frequently occurs and is mainly driven by RET‐independent bypass mechanisms. Son et al. show that SRC TKIs significantly inhibit PAK and AKT survival signaling and enhance the efficacy of RET TKIs in ...
Juhyeon Son +13 more
wiley +1 more source
Expression Characteristics of PAX7 and Its Prognostic Correlation in Breast Cancer. [PDF]
Silafu B, Huang J, Aizezi X.
europepmc +1 more source

